Respiratory syncytial virus (RSV) vaccine

Posted on August 28th, 2024

From 1 September 2024, those who turn 75 and those age 75 to 79 will be eligible for a free vaccine to protect them from respiratory syncytial virus (RSV).

RSV is an infectious disease of the airways and lungs. RSV infection often causes symptoms similar to a cold, including:

• cough
• sore throat
• sneezing
• a runny or blocked nose

It can also make you become wheezy or short of breath and lead to pneumonia and other life-threatening conditions. There is no specific treatment, and most infections will get better by themselves. Every year thousands of older adults need hospital care for RSV, and some of them will die. RSV can be more severe in people with medical conditions such as heart or lung disease or a weakened immune system.

Eligibility for the RSV vaccination

Everyone turning 75 years old on or after the 1 September 2024 will be offered a single dose of RSV vaccine. This is because older adults are more at risk of serious complications from RSV. You can still get the vaccine up to the day before you turn 80.

For the first year of the programme, the vaccine will also be offered to those who are already aged 75 to 79 years on 1 September 2024 as part of a catch up programme.

If you are not yet 75 the NHS will invite you for vaccination once you turn 75.

Flu and COVID-19 vaccines

RSV isn’t normally arranged to be given at the same appointment as your COVID-19 or flu vaccines.

In certain clinical circumstances, your doctor or nurse can safely offer them at the same time.